» Articles » PMID: 26317613

Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2015 Aug 29
PMID 26317613
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

HIV-1 Vpu prevents incorporation of tetherin (BST2/ CD317) into budding virions and targets it for ESCRT-dependent endosomal degradation via a clathrin-dependent process. This requires a variant acidic dileucine-sorting motif (ExxxLV) in Vpu. Structural studies demonstrate that recombinant Vpu/tetherin fusions can form a ternary complex with the clathrin adaptor AP-1. However, open questions still exist about Vpu's mechanism of action. Particularly, whether endosomal degradation and the recruitment of the E3 ubiquitin ligase SCFβTRCP1/2 to a conserved phosphorylated binding site, DSGNES, are required for antagonism. Re-evaluation of the phenotype of Vpu phosphorylation mutants and naturally occurring allelic variants reveals that the requirement for the Vpu phosphoserine motif in tetherin antagonism is dissociable from SCFβTRCP1/2 and ESCRT-dependent tetherin degradation. Vpu phospho-mutants phenocopy ExxxLV mutants, and can be rescued by direct clathrin interaction in the absence of SCFβTRCP1/2 recruitment. Moreover, we demonstrate physical interaction between Vpu and AP-1 or AP-2 in cells. This requires Vpu/tetherin transmembrane domain interactions as well as the ExxxLV motif. Importantly, it also requires the Vpu phosphoserine motif and adjacent acidic residues. Taken together these data explain the discordance between the role of SCFβTRCP1/2 and Vpu phosphorylation in tetherin antagonism, and indicate that phosphorylation of Vpu in Vpu/tetherin complexes regulates promiscuous recruitment of adaptors, implicating clathrin-dependent sorting as an essential first step in tetherin antagonism.

Citing Articles

Metformin facilitates viral reservoir reactivation and their recognition by anti-HIV-1 envelope antibodies.

Fert A, Richard J, Raymond Marchand L, Planas D, Routy J, Chomont N iScience. 2024; 27(9):110670.

PMID: 39252967 PMC: 11381840. DOI: 10.1016/j.isci.2024.110670.


Metformin Enhances Antibody-Mediated Recognition of HIV-Infected CD4 T-Cells by Decreasing Viral Release.

Fert A, Richard J, Raymond Marchand L, Planas D, Routy J, Chomont N bioRxiv. 2024; .

PMID: 38464135 PMC: 10925111. DOI: 10.1101/2024.02.15.580166.


Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity.

Marchitto L, Benlarbi M, Prevost J, Laumaea A, Descoteaux-Dinelle J, Medjahed H mBio. 2023; 14(4):e0078923.

PMID: 37404017 PMC: 10470595. DOI: 10.1128/mbio.00789-23.


Differential dysregulation of β-TrCP1 and -2 by HIV-1 Vpu leads to inhibition of canonical and non-canonical NF-κB pathways in infected cells.

Pickering S, Sumner J, Kerridge C, Perera M, Neil S mBio. 2023; 14(4):e0329322.

PMID: 37341489 PMC: 10470808. DOI: 10.1128/mbio.03293-22.


Microbial Pathogenesis in the Era of Spatial Omics.

Lempke S, May D, Ewald S Infect Immun. 2023; 91(7):e0044222.

PMID: 37255461 PMC: 10353406. DOI: 10.1128/iai.00442-22.


References
1.
Kueck T, Neil S . A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction. PLoS Pathog. 2012; 8(3):e1002609. PMC: 3315493. DOI: 10.1371/journal.ppat.1002609. View

2.
Weinelt J, Neil S . Differential sensitivities of tetherin isoforms to counteraction by primate lentiviruses. J Virol. 2014; 88(10):5845-58. PMC: 4019096. DOI: 10.1128/JVI.03818-13. View

3.
Neil S, Zang T, Bieniasz P . Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 2008; 451(7177):425-30. DOI: 10.1038/nature06553. View

4.
Roux K, Kim D, Raida M, Burke B . A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells. J Cell Biol. 2012; 196(6):801-10. PMC: 3308701. DOI: 10.1083/jcb.201112098. View

5.
Perez-Caballero D, Zang T, Ebrahimi A, McNatt M, Gregory D, Johnson M . Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell. 2009; 139(3):499-511. PMC: 2844890. DOI: 10.1016/j.cell.2009.08.039. View